// App-Quantinova.ai

4432 : Targeted TET oxidase activity through methyl-CpG binding domain extensively suppresses cancer cell proliferation

Researchers

Presenter

  • Shinichi Fukushige

Principal Investigators

  • Yasuhiko Mizuguchi

  • Kanchan Chakma

  • Yuriko Saiki

  • Akira Horii

Medical Centers

  • Tohoku University School of Medicine, Sendai, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Alpha-thalassemia myelodysplasia syndrome

  • Prostate cancer

  • Solid malignancies

Biomarkers

  • Glutathione S-transferase P1

Drug/Treatment

  • Decitabine

  • 5-Azacytidine

  • Tetracycline

  • Vidaza

  • glutathione

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved